FDA Vaccine Review: Child Death Claims Questioned

The Food and Drug Administration is contemplating significant shifts in vaccine safety testing and approval processes. These proposed changes are reportedly influenced by claims that mRNA COVID-19 vaccines led to the deaths of at least 10 children, a link attributed to myocarditis in an internal memo. However, this memo lacks concrete evidence, relying on unverified reports from the Vaccine Adverse Event Reporting System (VAERS).

Experts, including a pediatric cardiologist, argue that current data indicates myocarditis from COVID-19 vaccines is rare in children, with severe outcomes even less common. They assert that altering established safety procedures based on insufficient evidence could have severe repercussions, including limiting patient access and fostering distrust in public health initiatives. Proving a causal link requires more than just VAERS data, necessitating corroboration from other robust safety monitoring systems.

The article highlights that while investigating suspected vaccine deaths is vital, halting vaccines without sufficient justification can significantly damage public confidence. It underscores the importance of comparing vaccine risks against the risks of the diseases they prevent, noting that COVID-19 poses a far greater danger to children than the vaccine.